CD8A and neoplasm: The combination of PD-L1 antibodies and radiotherapy synergistically promoted antitumor immunity by increasing CD8 T-cell infiltration and decreasing the accumulation of myeloid-derived suppressor cells (MDSCs) and tumor-infiltrating regulatory T cells (iTregs) in a mouse model (40).